Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
New Blood Test Detects Cancer From Vague Symptoms
Research & Development New Blood Test Detects Cancer From Vague Symptoms

For countless patients experiencing persistent fatigue or unexplained pain, the journey toward a diagnosis is often a long and frustrating odyssey through the healthcare system. These non-specific symptoms, which can signal anything from a benign condition to a life-threatening malignancy, present

Could One Type of Fat Control Blood Pressure?
Research & Development Could One Type of Fat Control Blood Pressure?

The relentless global rise of hypertension has long been shadowed by its close companion, obesity, creating a public health crisis that has puzzled scientists and clinicians for decades. For years, the prevailing wisdom held that the sheer volume of body fat was the primary driver of high blood

UC San Diego Aims to End Liver Shortage With 3D Printing
Tech & Innovation UC San Diego Aims to End Liver Shortage With 3D Printing

The daunting reality for thousands of individuals is that a diagnosis of end-stage liver failure begins a desperate race against time, a wait for a life-saving organ that, for many, will never arrive. This critical shortage of donor organs has created a persistent crisis in modern medicine, with

Is Velaris the Future of Laboratory Automation?
Tech & Innovation Is Velaris the Future of Laboratory Automation?

The intricate and often painstaking work of scientific analysis is undergoing a profound transformation, driven not by a single breakthrough but by the quiet, strategic unification of industry specialists under a single, ambitious banner. As commercial and industrial laboratories face mounting

Regular Eye Exams Can Stop Glaucoma, the Silent Thief of Sight
Tech & Innovation Regular Eye Exams Can Stop Glaucoma, the Silent Thief of Sight

The world can fade to black not with a sudden closure of the eyes, but through a slow, imperceptible narrowing of one's peripheral vision that often goes unnoticed until it is far too late. This insidious process is the hallmark of glaucoma, a leading cause of irreversible blindness that affects

New Recipes Create Cancer-Fighting Immune Cells
Research & Development New Recipes Create Cancer-Fighting Immune Cells

Biopharma expert Ivan Kairatov joins us to discuss a groundbreaking advance in immunotherapy. While treatments like CAR-T cell therapy have shown incredible promise, they are not a solution for every patient, often because the necessary immune cells are rare or difficult to work with. Now,

New Drugs Destroy Previously Undruggable Proteins
Tech & Innovation New Drugs Destroy Previously Undruggable Proteins

A groundbreaking discovery has unveiled a class of small molecules that effectively teach the body to eliminate its own disease-causing components, a development that could rewrite the rules for treating some of the most stubborn medical conditions. An international team of scientists has

Study Reveals a Weakness in Aggressive Breast Cancer
Research & Development Study Reveals a Weakness in Aggressive Breast Cancer

For one of the most aggressive forms of breast cancer, the very molecular machinery that fuels its relentless growth has now been identified as its most critical and exploitable vulnerability, opening a new front in the war against this disease. This groundbreaking discovery shifts the focus from

Is WGS the Key to Unlocking PARP Inhibitor Therapy?
Research & Development Is WGS the Key to Unlocking PARP Inhibitor Therapy?

A comprehensive and detailed analysis from a recent study is reshaping the landscape of precision oncology, revealing the significant potential of whole-genome sequencing (WGS) to revolutionize how patient responses to PARP inhibitor cancer treatments are predicted. The findings, published in the

Scientists Grow Meat on Scaffolds Made From Beer Waste
Biotech & Bioprocessing Scientists Grow Meat on Scaffolds Made From Beer Waste

A significant obstacle preventing cultivated meat from becoming a staple in grocery stores has been the challenge of creating affordable, complex structures that mimic the texture and composition of traditional cuts like steak or chops. Researchers at University College London have unveiled a novel

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later